Inhaler
Latest Novartis AG Patents:
- Antibody molecules to LAG-3 and uses thereof
- Crystalline forms OF N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxypyrrolidin-1-yl]-5-(1H-pyrazol-5-yl)pyridine-3-carboxamide
- Crystalline forms of N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxypyrrolidin-1-yl]-5-(1H-pyrazol-5-yl)pyridine-3-carboxamide
- Pyrazolopyridine derivatives and uses thereof
- Methods for improving the efficacy and expansion of immune cells
Description
Claims
The ornamental design of an inhaler, as shown and described.
Referenced Cited
Patent History
Patent number: D579546
Type: Grant
Filed: Oct 29, 2007
Date of Patent: Oct 28, 2008
Assignee: Novartis AG (Basel)
Inventors: Martin Birath (Stockholm), Hans Himbert (Stockholm), Sofia Jacobsson (Bromma), Thomas Nilsson (Bromma), Ulrika Vejbrink (Hägersten)
Primary Examiner: Ian Simmons
Assistant Examiner: Christopher Lee
Attorney: John W. Kung
Application Number: 29/292,807
Type: Grant
Filed: Oct 29, 2007
Date of Patent: Oct 28, 2008
Assignee: Novartis AG (Basel)
Inventors: Martin Birath (Stockholm), Hans Himbert (Stockholm), Sofia Jacobsson (Bromma), Thomas Nilsson (Bromma), Ulrika Vejbrink (Hägersten)
Primary Examiner: Ian Simmons
Assistant Examiner: Christopher Lee
Attorney: John W. Kung
Application Number: 29/292,807
Classifications
Current U.S. Class:
Respirator, Vaporizer, Or Inhalation Tube (4) (D24/110)